Here we demonstrate that sunitinib significantly augments TRAIL-induced JNK phosphorylation, which leads to downregulation of XIAP and enhanced anticancer activity in both in vitro and in vivo colon cancer models. The gene discussed is TNFSF10; the disease is malignant colon neoplasm.